loadpatents
name:-0.3417649269104
name:-0.0064699649810791
name:-0.00090694427490234
Hunter; John Joseph Patent Filings

Hunter; John Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hunter; John Joseph.The latest application filed is for "novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16".

Company Profile
0.5.29
  • Hunter; John Joseph - Oakland CA
  • Hunter; John Joseph - Somerville MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel 27411, 23413, 22438, 23553, 25278, 26212, Narc Sc1, Narc 10a, Narc 1, Narc 12, Narc 13, Narc17, Narc 25, Narc 3, Narc 4, Narc 7, Narc 8, Narc 11, Narc 14a, Narc 15, Narc 16, Narc 19, Narc 20, Narc 26, Narc 27, Narc 28, Narc 30, Narc 5, Narc 6, Narc 9, Narc 10c, Narc 8b, Narc 9, Narc2a, Narc 16
App 20100291099 - Glucksmann; Maria A. ;   et al.
2010-11-18
21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
Grant 7,696,316 - Kapeller-Libermann , et al. April 13, 2
2010-04-13
Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16
App 20090269350 - Glucksmann; Maria A. ;   et al.
2009-10-29
Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
App 20090263860 - Meyers; Rachel E. ;   et al.
2009-10-22
14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
App 20080051322 - Glucksmann; Maria A. ;   et al.
2008-02-28
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
App 20070178515 - Meyers; Rachel ;   et al.
2007-08-02
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
Grant 7,214,502 - Meyers , et al. May 8, 2
2007-05-08
Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
App 20070087375 - Hunter; John Joseph ;   et al.
2007-04-19
Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 1048
App 20070078088 - Hunter; John Joseph ;   et al.
2007-04-05
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
App 20070037203 - Kapeller-Libermann; Rosana ;   et al.
2007-02-15
62112, a novel human dehydrogenase and uses thereof
Grant 7,166,428 - Meyers , et al. January 23, 2
2007-01-23
Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16
App 20060116508 - Glucksmann; Maria A. ;   et al.
2006-06-01
Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
App 20060088907 - Meyers; Rachel E. ;   et al.
2006-04-27
27411, a novel human PGP synthase
Grant 7,029,895 - Glucksmann , et al. April 18, 2
2006-04-18
Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
App 20040058355 - Kapeller-Libermann, Rosana ;   et al.
2004-03-25
Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor
App 20040033509 - Meyers, Rachel E. ;   et al.
2004-02-19
Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16
App 20040009553 - Glucksmann, Maria A. ;   et al.
2004-01-15
Methods for using 22045, a human cyclic nucleotide phosphodiesterase
Grant 6,673,564 - Kapeller-Libermann , et al. January 6, 2
2004-01-06
14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
App 20030224417 - Glucksmann, Maria A. ;   et al.
2003-12-04
Methods for using 22045, a human cyclic nucleotide phosphodiesterase
App 20030215898 - Kapeller-Libermann, Rosana ;   et al.
2003-11-20
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
App 20030175786 - Meyers, Rachel ;   et al.
2003-09-18
Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 1048
App 20030157082 - Hunter, John Joseph ;   et al.
2003-08-21
Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
App 20030153018 - Hunter, John Joseph ;   et al.
2003-08-14
Methods of using 46828, a human acyl-CoA synthetase
App 20030118507 - Hunter, John Joseph
2003-06-26
Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
App 20030113777 - Hunter, John Joseph
2003-06-19
21910, a novel human membrane-associated guanylate kinase and uses thereof
App 20030108934 - Kapeller-Libermann, Rosana ;   et al.
2003-06-12
9136, a human aldehyde dehydrogenase family member and uses therefor
App 20030100034 - Hunter, John Joseph
2003-05-29
21163, a novel human prolyl oligopeptidase and uses therefor
App 20030096392 - Hunter, John Joseph ;   et al.
2003-05-22
Methods of using 22417, a novel human aminoprotease family member
App 20030091506 - Hunter, John Joseph
2003-05-15
23413, a novel human ubiquitin protease
App 20020152481 - Kapeller-Libermann, Rosana ;   et al.
2002-10-17
62112, a novel human dehydrogenase and uses thereof
App 20020127680 - Meyers, Rachel ;   et al.
2002-09-12
23155 novel protein human 5-alpha reductases and uses therefor
App 20020086387 - Meyers, Rachel ;   et al.
2002-07-04
Methods For Using 22045, A Human Cyclic Nucleotide Phosphodiesterase
App 20020081633 - KAPELLER-LIBERMANN, ROSANA ;   et al.
2002-06-27
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
App 20020025931 - Meyers, Rachel ;   et al.
2002-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed